Fareva and ApiJect sign 10-year licensing deal for BFS production lines

Fareva and ApiJect Systems signed a 10-year licensing agreement to install three Blow-Fill-Seal production lines in France, with Fareva investing over €50 million. The lines will be able to fill-finish more than 500 million doses per year of vaccines and injectable drugs, starting in H2 2022.

“Fareva intends to invest more than €50M (US$ 56.5M) for these three manufacturing lines, with support from the Government of France.”pharmaceuticalonline.com

• 1 source
• pharmaceuticalonline.comFareva And Apiject Sign 10 Year Licensing Agreement; To Install 3 New Blow-Fill-Seal Production LinesDec 9, 2021

Summarized from public sources; check the original articles before acting on it.